Drug Shortage Report for MYLAN-VERAPAMIL SR

Last updated on 2020-01-17 History
Report ID 91047
Drug Identification Number 02210347
Brand name MYLAN-VERAPAMIL SR
Common or Proper name VERAPAMIL SR
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) VERAPAMIL HYDROCHLORIDE
Strength(s) 120MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 100 BT
ATC code C08DA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-08-06
Estimated end date 2020-01-17
Actual end date 2020-01-16
Shortage status Resolved
Updated date 2020-01-17
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2020-01-17 French Compare
v11 2020-01-17 English Compare
v10 2020-01-13 French Compare
v9 2020-01-13 English Compare
v8 2020-01-09 French Compare
v7 2020-01-09 English Compare
v6 2020-01-09 French Compare
v5 2020-01-09 English Compare
v4 2019-09-17 French Compare
v3 2019-09-17 English Compare
v2 2019-08-07 French Compare
v1 2019-08-07 English Compare